Skip to main content
Bio-Gate AG logo

Bio-Gate AG — Investor Relations & Filings

Ticker · BIG1 ISIN · DE000BGAG981 LEI · 391200G5LKTIOTZOXP90 F Manufacturing
Open in API
Filings indexed 242 across all filing types
Latest filing 2014-03-25 Audit Report / Informat…
Country DE Germany
Listing F BIG1

About Bio-Gate AG

https://www.bio-gate.de/en/

Bio-Gate AG is a provider of innovative technologies and customized solutions for health and hygiene, specializing in antimicrobial and antiviral strategies. The company enhances materials and products by incorporating its unique silver-based technologies, such as MicroSilver BG™. Key applications are concentrated in the medical technology sector, including the coating of medical implants and wound dressings to prevent infections. The company's technologies are also utilized in derma-cosmetics and veterinary care products. Furthermore, Bio-Gate provides solutions for industrial and consumer goods, imparting antimicrobial properties to items like paints, coatings, plastics, and textiles.

Recent filings

Filing Released Lang Actions
Datum:25.03.2014
Audit Report / Information Classification · 98% confidence The document is a 'Jahresabschluss' (Annual Financial Statement) for Bio-Gate AG for the fiscal year ending December 31, 2012. It contains a balance sheet (Bilanz), profit and loss statement (Gewinn- und Verlustrechnung), and notes (Anhang). While it is a standalone financial report, it functions as the primary annual financial disclosure for the company, which aligns with the 10-K category for annual financial performance reporting. FY 2012
2014-03-25 German
Bio-Gate AG erwartet 2014 deutliches Wachstum
Earnings Release Classification · 100% confidence The document is a news release dated February 26, 2014, titled "Bio-Gate AG erwartet 2014 deutliches Wachstum" (Bio-Gate AG expects significant growth in 2014). It provides preliminary financial figures for the full year 2013 (revenue, loss reduction) and gives an outlook for 2014. It explicitly mentions that the final figures for 2013 are expected to be published in April. This structure—announcing preliminary results, key highlights, and an outlook for the coming year, while noting the final report is forthcoming—is characteristic of an Earnings Release (ER). It is not the comprehensive Annual Report (10-K) or the Interim Report (IR), nor is it merely an announcement of a report's publication (RPA), as it contains substantive preliminary financial data and management commentary. FY 2013
2014-02-26 German
Bio-Gate AG: Bio-Gate starkt Kapitalkraft
Capital/Financing Update Classification · 98% confidence The document is a corporate news release dated February 13, 2014, with the headline "Bio-Gate AG: Bio-Gate stärkt Kapitalkraft" (Bio-Gate strengthens capital power). The content explicitly discusses the successful placement of a zero-coupon convertible bond, resulting in gross proceeds of approximately 0.24 million Euro. This action directly relates to fundraising, financing activities, and capital structure changes. This aligns perfectly with the definition for Capital/Financing Update (CAP). Although it mentions future publication of the Annual Report, the primary subject of this specific filing is the completed financing transaction.
2014-02-13 German
Bio-Gate AG: Bio-Gate schliet Barkapitalerhohung erfolgreich ab
Share Issue/Capital Change Classification · 99% confidence The document is a press release dated September 26, 2013, titled "Bio-Gate schließt Barkapitalerhöhung erfolgreich ab" (Bio-Gate successfully closes cash capital increase). It explicitly details the placement of new shares, the gross proceeds (€0.3 million), and the resulting increase in share capital. This content directly relates to fundraising, financing activities, and capital structure changes. Therefore, it fits the definition of 'Capital/Financing Update' (CAP). Although it is a news release, the core subject matter is the capital action itself, making CAP more specific than a general RPA or RNS.
2013-09-26 German
Bio-Gate AG: Hauptversammlung wahlt neues Aufsichtsratsmitglied
AGM Information Classification · 99% confidence The document text explicitly mentions 'Hauptversammlung' (General Meeting) multiple times, stating that the meeting elected a new member to the Supervisory Board ('Aufsichtsrat'). The title is 'Bio-Gate AG: Hauptversammlung wählt neues Aufsichtsratsmitglied'. This directly relates to the proceedings and outcomes of an Annual General Meeting. Therefore, the appropriate classification is AGM Information (AGM-R). The document is a news release about the AGM outcome, not a presentation (IP) or voting results declaration (DVA), but rather information stemming from the meeting itself.
2013-08-22 German
Bio-Gate mit starkem Umsatzwachstum im ersten Halbjahr 2013 - Fehlbetrag deutlich gesunken
Earnings Release Classification · 100% confidence The document is a news release dated August 16, 2013, titled "Bio-Gate mit starkem Umsatzwachstum im ersten Halbjahr 2013 – Fehlbetrag deutlich gesunken". It explicitly details financial performance metrics for the first half of the year (Umsatz steigt um 50 Prozent auf gut 1,4 Mio. Euro; Halbjahresfehlbetrag auf 0,8 Mio. Euro gesunken). This content structure—key financial highlights for a period shorter than a year, released shortly after the period ends—is characteristic of an Earnings Release (ER). It is not a comprehensive report (like 10-K or IR) nor is it merely an announcement of a report's publication (RPA). H1 2013
2013-08-16 German

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.